Another Final-Stage COVID-19 Test Vaccine In The United States
Public health experts say that in addition to the two vaccines currently distributed– one developed by Pfizer and its German partner BioNTech, and the other by Moderna– it is crucial to have more options to supply enough vaccines to the country and the world. The candidate developed by Novavax Inc. is the fifth to reach the final phase of clinical trials in the…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Venice mayor plans to revisit Medicaid expansion in January
Quarles opts out of Beshear's vaccine invitation
Advisor News
- CFP Board appoints K. Dane Snowden as CEO
- TIAA unveils ‘policy roadmap’ to boost retirement readiness
- 2026 may bring higher volatility, slower GDP growth, experts say
- Why affluent clients underuse advisor services and how to close the gap
- America’s ‘confidence recession’ in retirement
More Advisor NewsAnnuity News
- Insurer Offers First Fixed Indexed Annuity with Bitcoin
- Assured Guaranty Enters Annuity Reinsurance Market
- Ameritas: FINRA settlement precludes new lawsuit over annuity sales
- Guaranty Income Life Marks 100th Anniversary
- Delaware Life Insurance Company Launches Industry’s First Fixed Indexed Annuity with Bitcoin Exposure
More Annuity NewsHealth/Employee Benefits News
- CATHOLIC UNIVERSITY IN ILLINOIS STILL COVERS 'ABORTION CARE' WITH CAMPUS INSURANCE
- Major health insurer overspent health insurance funds
- OPINION: Lawmakers should extend state assistance for health care costs
- House Dems roll out affordability plan, take aim at Reynolds' priorities
- Municipal healthcare costs loom as officials look to fiscal 2027 budget
More Health/Employee Benefits NewsLife Insurance News